Correlation Between Capital Income and Cardiff Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Capital Income and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capital Income and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capital Income Builder and Cardiff Oncology, you can compare the effects of market volatilities on Capital Income and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capital Income with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capital Income and Cardiff Oncology.

Diversification Opportunities for Capital Income and Cardiff Oncology

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Capital and Cardiff is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Capital Income Builder and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Capital Income is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capital Income Builder are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Capital Income i.e., Capital Income and Cardiff Oncology go up and down completely randomly.

Pair Corralation between Capital Income and Cardiff Oncology

Assuming the 90 days horizon Capital Income is expected to generate 13.28 times less return on investment than Cardiff Oncology. But when comparing it to its historical volatility, Capital Income Builder is 15.28 times less risky than Cardiff Oncology. It trades about 0.08 of its potential returns per unit of risk. Cardiff Oncology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  187.00  in Cardiff Oncology on November 3, 2024 and sell it today you would earn a total of  216.00  from holding Cardiff Oncology or generate 115.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.6%
ValuesDaily Returns

Capital Income Builder  vs.  Cardiff Oncology

 Performance 
       Timeline  
Capital Income Builder 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Capital Income Builder has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental drivers, Capital Income is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Cardiff Oncology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Capital Income and Cardiff Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Capital Income and Cardiff Oncology

The main advantage of trading using opposite Capital Income and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capital Income position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.
The idea behind Capital Income Builder and Cardiff Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world